XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Series E Cumulative Redeemable Preferred Stock
Preferred Stock
Series E Cumulative Redeemable Preferred Stock
Additional Paid In Capital
Series E Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series E Cumulative Redeemable Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Additional Paid In Capital
Series F Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series F Cumulative Redeemable Preferred Stock
Series G Cumulative Redeemable Preferred Stock
Preferred Stock
Series G Cumulative Redeemable Preferred Stock
Additional Paid In Capital
Series G Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series G Cumulative Redeemable Preferred Stock
Series H Cumulative Redeemable Preferred Stock
Preferred Stock
Series H Cumulative Redeemable Preferred Stock
Additional Paid In Capital
Series H Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series H Cumulative Redeemable Preferred Stock
Series I Cumulative Redeemable Preferred Stock
Preferred Stock
Series I Cumulative Redeemable Preferred Stock
Additional Paid In Capital
Series I Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series I Cumulative Redeemable Preferred Stock
Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings
Cumulative dividends and distributions
Non-Controlling Interest in Consolidated Joint Venture
Total
Beginning Balance at Dec. 31, 2020                                         $ 190,000 $ 2,156 $ 2,586,108 $ 913,766 $ (1,643,386) $ 40,735 $ 2,089,379
Beginning Balance (in shares) at Dec. 31, 2020                                         7,600,000 215,593,401          
Increase (Decrease) in Stockholders' Equity                                                      
Amortization of deferred stock compensation                                             2,869       2,869
Issuance of restricted common stock, net                                           $ 6 (3,522)       (3,516)
Issuance of restricted common stock, net (in shares)                                           581,683          
Preferred stock dividends and dividends payable     $ (1,998) $ (1,998)     $ (1,209) $ (1,209)                                      
Contribution from noncontrolling interest                                                   1,375 1,375
Net income (loss)                                               (53,312)   (1,975) (55,287)
Ending Balance at Mar. 31, 2021                                         $ 190,000 $ 2,162 2,585,455 860,454 (1,646,593) 40,135 2,031,613
Ending Balance (in shares) at Mar. 31, 2021                                         7,600,000 216,175,084          
Beginning Balance at Dec. 31, 2020                                         $ 190,000 $ 2,156 2,586,108 913,766 (1,643,386) 40,735 2,089,379
Beginning Balance (in shares) at Dec. 31, 2020                                         7,600,000 215,593,401          
Increase (Decrease) in Stockholders' Equity                                                      
Net income (loss)                                                     (105,329)
Ending Balance at Sep. 30, 2021                                         $ 281,250 $ 2,193 2,629,148 810,075 (1,660,675) 40,472 2,102,463
Ending Balance (in shares) at Sep. 30, 2021                                         11,250,000 219,333,783          
Beginning Balance at Mar. 31, 2021                                         $ 190,000 $ 2,162 2,585,455 860,454 (1,646,593) 40,135 2,031,613
Beginning Balance (in shares) at Mar. 31, 2021                                         7,600,000 216,175,084          
Increase (Decrease) in Stockholders' Equity                                                      
Amortization of deferred stock compensation                                             4,784       4,784
Issuance of restricted common stock, net                                           $ (1) (1,360)       (1,361)
Issuance of restricted common stock, net (in shares)                                           (45,661)          
Preferred stock dividends and dividends payable     (1,554) (1,554)     (1,209) (1,209)     $ (292) $ (292)     $ (724) $ (724)                      
Net proceeds from issuance of common stock                                           $ 29 37,630       37,659
Number of shares of common stock issued (in shares)                                           2,913,682          
Net issuance of preferred stock in connection with hotel acquisition                 $ 66,250 $ (142)   66,108                              
Net issuance of preferred stock in connection with hotel acquisition (in shares)                 2,650,000                                    
Net proceeds from issuance of preferred stock                         $ 115,000 $ (3,801)   111,199                      
Number of shares of preferred stock issued (in shares)                         4,600,000                            
Redemption of preferred stock $ (115,000) $ 4,016 $ (4,016) $ (115,000)                                              
Redemption of preferred stock (in shares) (4,600,000)                                                    
Net income (loss)                                               (27,322)   (596) (27,918)
Ending Balance at Jun. 30, 2021                                         $ 256,250 $ 2,190 2,626,582 833,132 (1,654,388) 39,539 2,103,305
Ending Balance (in shares) at Jun. 30, 2021                                         10,250,000 219,043,105          
Increase (Decrease) in Stockholders' Equity                                                      
Amortization of deferred stock compensation                                             3,289       3,289
Issuance of restricted common stock, net                                           $ 5 (5)        
Issuance of restricted common stock, net (in shares)                                           526,084          
Forfeiture of restricted common stock                                           $ (2) 2        
Forfeiture of restricted common stock (in shares)                                           (235,406)          
Preferred stock dividends and dividends payable             (551) (551)     (164) (164)     (1,761) (1,761)     $ (1,187) $ (1,187)              
Net proceeds from issuance of preferred stock                                 $ 100,000 $ (3,344)   96,656              
Number of shares of preferred stock issued (in shares)                                 4,000,000                    
Redemption of preferred stock         $ (75,000) $ 2,624 $ (2,624) $ (75,000)                                      
Redemption of preferred stock (in shares)         (3,000,000)                                            
Net income (loss)                                               (23,057)   933 (22,124)
Ending Balance at Sep. 30, 2021                                         $ 281,250 $ 2,193 2,629,148 810,075 (1,660,675) 40,472 2,102,463
Ending Balance (in shares) at Sep. 30, 2021                                         11,250,000 219,333,783          
Beginning Balance at Dec. 31, 2021                                         $ 281,250 $ 2,193 2,631,484 948,064 (1,664,024) 40,807 2,239,774
Beginning Balance (in shares) at Dec. 31, 2021                                         11,250,000 219,333,783          
Increase (Decrease) in Stockholders' Equity                                                      
Amortization of deferred stock compensation                                             3,701       3,701
Issuance of restricted common stock, net                                           $ 2 (3,353)       (3,351)
Issuance of restricted common stock, net (in shares)                                           213,179          
Preferred stock dividends and dividends payable                     (587) (587)     (1,761) (1,761)     (1,425) (1,425)              
Repurchases of outstanding common stock                                           $ (38) (43,427)       (43,465)
Repurchases of outstanding common stock (in shares)                                           (3,879,025)          
Net income (loss)                                               13,989   1,134 15,123
Ending Balance at Mar. 31, 2022                                         $ 281,250 $ 2,157 2,588,405 962,053 (1,667,797) 41,941 2,208,009
Ending Balance (in shares) at Mar. 31, 2022                                         11,250,000 215,667,937          
Beginning Balance at Dec. 31, 2021                                         $ 281,250 $ 2,193 2,631,484 948,064 (1,664,024) 40,807 2,239,774
Beginning Balance (in shares) at Dec. 31, 2021                                         11,250,000 219,333,783          
Increase (Decrease) in Stockholders' Equity                                                      
Net income (loss)                                                     73,303
Ending Balance at Sep. 30, 2022                                         $ 281,250 $ 2,116 2,487,931 1,017,890 (1,685,531)   2,103,656
Ending Balance (in shares) at Sep. 30, 2022                                         11,250,000 211,570,211          
Beginning Balance at Mar. 31, 2022                                         $ 281,250 $ 2,157 2,588,405 962,053 (1,667,797) 41,941 2,208,009
Beginning Balance (in shares) at Mar. 31, 2022                                         11,250,000 215,667,937          
Increase (Decrease) in Stockholders' Equity                                                      
Amortization of deferred stock compensation                                             2,971       2,971
Forfeiture of restricted common stock (in shares)                                           (34,807)          
Preferred stock dividends and dividends payable                     (587) (587)     (1,761) (1,761)     (1,425) (1,425)              
Distribution to noncontrolling interest                                                   (5,500) (5,500)
Issuance of restricted common stock                                           $ 1 (92)       (91)
Issuance of restricted common stock (in shares)                                           53,616          
Repurchases of outstanding common stock                                           $ (33) (34,482)       (34,515)
Repurchases of outstanding common stock (in shares)                                           (3,235,958)          
Acquisition of noncontrolling interest, net                                             (62,564)     (38,784) (101,348)
Net income (loss)                                               35,349   $ 2,343 37,692
Ending Balance at Jun. 30, 2022                                         $ 281,250 $ 2,125 2,494,238 997,402 (1,671,570)   2,103,445
Ending Balance (in shares) at Jun. 30, 2022                                         11,250,000 212,450,788          
Increase (Decrease) in Stockholders' Equity                                                      
Amortization of deferred stock compensation                                             2,350       2,350
Common stock distributions and distributions payable                                                 (10,610)   (10,610)
Preferred stock dividends and dividends payable                     $ (165) $ (165)     $ (1,761) $ (1,761)     $ (1,425) $ (1,425)              
Repurchases of outstanding common stock                                           $ (9) (8,657)       (8,666)
Repurchases of outstanding common stock (in shares)                                           (880,577)          
Net income (loss)                                               20,488     20,488
Ending Balance at Sep. 30, 2022                                         $ 281,250 $ 2,116 $ 2,487,931 $ 1,017,890 $ (1,685,531)   $ 2,103,656
Ending Balance (in shares) at Sep. 30, 2022                                         11,250,000 211,570,211